Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Setting Up a Haplobank: Issues and Solutions

16 Apr 2015

Abstract excerpt

The development of induced pluripotent stem cells offers the possibility of the scalable manufacture of cellular therapies for regenerative medicine. Moreover, donors can be selected on the basis of major transplant antigen systems to match the widest possible number of recipients worldwide, reducing the likely risk of immunological rejection and the degree of immune suppression or tolerance required. If such...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Ethics and Regulation
Share to CRISPR and Genetic Engineering
Share to Pluripotent Stem Cells Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26225325
DOI: 10.1007/s40778-015-0011-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Setting Up a Haplobank: Issues and SolutionsPMID 26225325Read ↗

Haplobanking induced pluripotent stem cells for clinical useSemantic proximity Read ↗

Current Landscape of iPSC HaplobanksSemantic proximity Read ↗

Toward the development of a global induced pluripotent stem cell library.Semantic proximity Read ↗

Adapting Cord Blood Collection and Banking Standard Operating Procedures for HLA-Homozygous Induced Pluripotent Stem Cells Production and Banking for Clinical ApplicationSemantic proximity Read ↗

Potential and Limitation of HLA-Based Banking of Human Pluripotent Stem Cells for Cell TherapySemantic proximity Read ↗

A clinical-grade HLA haplobank of human induced pluripotent stem cells matching approximately 40% of the Japanese populationSemantic proximity Read ↗

Harnessing Global HLA Data for Enhanced Patient Matching in iPSC HaplobanksSemantic proximity Read ↗

Haplotype-Based Banking of Human Pluripotent Stem Cells for Transplantation: Potential and LimitationsSemantic proximity Read ↗

Identification and Re-consent of Existing Cord Blood Donors for Creation of Induced Pluripotent Stem Cell Lines for Potential Clinical ApplicationsSemantic proximity Read ↗

Overview: an iPS cell stock at CiRASemantic proximity Read ↗

Translational Prospects for Human Induced Pluripotent Stem CellsSemantic proximity Read ↗

Do Human Leukocyte Antigen-Typed Cellular Therapeutics Based on Induced Pluripotent Stem Cells Make Commercial Sense?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.